v3.26.1
BALANCE SHEET ACCOUNT DETAILS - Schedule of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Balance Sheet Related Disclosures [Abstract]    
Compensation $ 1,934 $ 3,475
Drug product manufacturing subcontractor 344 292
Commercial, marketing and sales 86 818
Insurance 0 265
Accrued interest 0 234
Commercialization milestone and royalties payable 8,173 7,819
Accrued gross-to-net adjustments 1,750 1,778
Other 548 683
Total accrued expenses $ 12,835 $ 15,364